Eway, Rey S.
HRN: 29-46-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2026
MUPIROCIN 2%, 15G (TUBE)
08/07/2026
08/14/2026
TOPICAL
Ample Amount
BID
Lacerated Wound Nasal Area Extending To Right Maxillary Area
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: